Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 18;113(12):1898-1907.e6.
doi: 10.1016/j.neuron.2025.03.035. Epub 2025 Apr 21.

The interpeduncular nucleus blunts the rewarding effect of nicotine

Affiliations

The interpeduncular nucleus blunts the rewarding effect of nicotine

Joachim Jehl et al. Neuron. .

Abstract

Nicotine stimulates ventral tegmental area (VTA) dopaminergic neurons, producing a rewarding effect that drives tobacco consumption. The interpeduncular nucleus (IPN) is thought to become engaged at high nicotine doses to limit drug intake, but its response dynamics are unknown. We developed a chemogenetic approach using a "suicide" antagonist that selectively attaches to designer β4 nicotinic acetylcholine receptors (nAChRs) in genetically modified mice, enabling sustained and pharmacologically specific antagonism. Local infusion in the IPN revealed that nicotine, even at low doses, simultaneously activates and inhibits two distinct populations of IPN neurons, with β4-containing nAChRs mediating only the activation response. Blocking nicotine-induced IPN activation enhanced VTA responses and increased the drug's rewarding effect in a conditioned place preference paradigm. Moreover, optogenetic inhibition of IPN projections to the laterodorsal tegmental nucleus (LDTg) replicated these behavioral effects. Our findings indicate that the IPN acts as a regulatory brake on the nicotine reward circuit via the LDTg.

Keywords: Maleimide; chemogenetics; dopamine; interpeduncular nucleus; medial habenula; nicotine addiction; nicotinic acetylcholine receptors; reinforcement; ventral tegmental area.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors declare no competing interests.

References

    1. WHO report on the global tobacco epidemic, 2021: addressing new and emerging products (2021).
    1. Taly A, Corringer P-J, Guedin D, Lestage P, and Changeux J-P (2009). Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov 8, 733–750. 10.1038/nrd2927. - DOI - PubMed
    1. Volkow ND, and Morales M. (2015). The Brain on Drugs: From Reward to Addiction. Cell 162, 712–725. 10.1016/j.cell.2015.07.046. - DOI - PubMed
    1. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, Evrard A, Cazala P, Cormier A, Mameli-Engvall M, et al. (2005). Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436, 103–107. 10.1038/nature03694. - DOI - PubMed
    1. Wills L, Ables JL, Braunscheidel KM, Caligiuri SPB, Elayouby KS, Fillinger C, Ishikawa M, Moen JK, and Kenny PJ (2022). Neurobiological Mechanisms of Nicotine Reward and Aversion. Pharmacological Reviews 74, 271–310. 10.1124/pharmrev.121.000299. - DOI - PMC - PubMed

LinkOut - more resources